MSToronto 2026

De timer heeft de streefdatum bereikt, u kunt het onderdeel opnieuw configureren of verwijderen.

At this year's congress, Roche’s scientific program brings together global leaders to share clinical insights and real-word evidence on the most critical clinical questions facing neuroimmunology today:

Ocrevus Multiple sclerosis
Acting early: high-efficacy intervention across the MS continuum
Ocrevus Multiple sclerosis
Time for What Matters: Ocrevus SC
Ocrevus Multiple sclerosis
Shaping MS care: Scientific innovation to improve patient outcomes

Ocrevus Multiple sclerosis
MS Disease Biology in Focus: Targeting Peripheral and CNS Mechanisms
Ocrevus Multiple sclerosis
Hit the target - IL-6 in rare neuroimmunological conditions

View the Full Agenda

View the Congress website

These Roche-sponsored events are intended for HCPs and members of the scientific community and are not intended for physicians practising in the United States of America (USA). The data and presentations are based on European Medicines Agency (EMA) regulations and labels. Content presented herein may discuss formulations, indications, or data that are not approved or aligned with the labelling in other jurisdictions. Local prescribing information should always be consulted. Subcutaneous Ocrevus is not authorized for sale in Canada.

Roche proactively tries to ensure medical education is as widely accessible as possible for HCPs all over the world. These events are organised and funded by Roche.

The content of these events is owned by: F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.